000148089 001__ 148089
000148089 005__ 20250114155432.0
000148089 0247_ $$2doi$$a10.1016/j.arteri.2019.03.004
000148089 0248_ $$2sideral$$a115045
000148089 037__ $$aART-2019-115045
000148089 041__ $$aspa
000148089 100__ $$aMostaza J.M.
000148089 245__ $$aEstándares SEA 2019 para el control global del riesgo cardiovascular
000148089 260__ $$c2019
000148089 5060_ $$aAccess copy available to the general public$$fUnrestricted
000148089 5203_ $$aOne of the main goals of the Spanish Society of Arteriosclerosis is to contribute to a wider and greater knowledge of vascular disease, its prevention and treatment. Cardiovascular diseases are the leading cause of death in our country and also lead to a high degree of disability and health expenditure. Arteriosclerosis is a multifactorial disease, this is why its prevention requires a global approach that takes into account the different risk factors with which it is associated. Thus, this document summarizes the current level of knowledge and integrates recommendations and procedures to be followed for patients with established cardiovascular disease or high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or those in special situations. It also includes the estimation of vascular risk, the diagnostic criteria of the different entities that are cardiovascular risk factors, and presents general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not often mentioned in the literature, such as the organisation of a vascular risk consultation.
000148089 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000148089 592__ $$a0.277$$b2019
000148089 593__ $$aPharmacology (medical)$$c2019$$dQ3
000148089 593__ $$aCardiology and Cardiovascular Medicine$$c2019$$dQ3
000148089 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000148089 700__ $$aPintó X.
000148089 700__ $$aArmario P.
000148089 700__ $$aMasana L.
000148089 700__ $$aAscaso J.F.
000148089 700__ $$aValdivielso P.
000148089 700__ $$aArrobas Velilla T.
000148089 700__ $$aUnidad de Lípidos Á.B.
000148089 700__ $$aCalmarza P.
000148089 700__ $$aCebollada J.
000148089 700__ $$0(orcid)0000-0001-7043-0952$$aCiveira F.$$uUniversidad de Zaragoza
000148089 700__ $$aCuende Melero J.I.
000148089 700__ $$aSalan M.E.
000148089 700__ $$aFernández Pardo J.
000148089 700__ $$aGodoy D.
000148089 700__ $$aGuijarro C.
000148089 700__ $$aJericó C.
000148089 700__ $$0(orcid)0000-0003-3963-0846$$aLaclaustra M.
000148089 700__ $$aRallo C.L.
000148089 700__ $$aMillán J.
000148089 700__ $$aMiranda J.L.
000148089 700__ $$aMuñiz-Grijalvo O.
000148089 700__ $$aPáramo J.A.
000148089 700__ $$aPascual V.
000148089 700__ $$aPedro-Botet J.
000148089 700__ $$aPérez-Martínez P.
000148089 700__ $$aPlana N.
000148089 700__ $$0(orcid)0000-0002-1309-4363$$aPuzo J.$$uUniversidad de Zaragoza
000148089 700__ $$aReal J.T.
000148089 700__ $$aRos E.
000148089 700__ $$aSánchez Chaparro M.Á.
000148089 700__ $$aVila L.
000148089 700__ $$aen nombre de la Sociedad Española de Arteriosclerosis
000148089 700__ $$aMiembros de la Sociedad Espanola de Arteriosclerosis
000148089 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000148089 773__ $$g31, Sup. 1 (2019), 1-43$$pClín. investig. arterioscler.$$tClinica e Investigacion en Arteriosclerosis$$x0214-9168
000148089 8564_ $$s3168129$$uhttps://zaguan.unizar.es/record/148089/files/texto_completo.pdf$$yVersión publicada
000148089 8564_ $$s3119019$$uhttps://zaguan.unizar.es/record/148089/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000148089 909CO $$ooai:zaguan.unizar.es:148089$$particulos$$pdriver
000148089 951__ $$a2025-01-13-14:27:32
000148089 980__ $$aARTICLE